(1)
SGLT2i Pharmacological Treatment in Type 2 Diabetes Mellitus Control and Its Underlying Obesity. Rev Port Med Geral Fam 2024, 40 (2), 148-56. https://doi.org/10.32385/rpmgf.v40i2.13647.